Lever Bio
5 known investors
Find your way into Lever Bio
113 people in our graph share verified history with the Lever Bio team — schools, employers, funds. One of them is your warm intro.
Stefano Galiassounlockedknows Pietro Puglisi · together at Politecnico di Torino (overlapped)
knows the team · via Resalis Therapeutics
×6knows the team · via Politecnico di Torino
knows the team · via NeoPhore Ltd
×3knows the team · via Collège des Ingénieurs
Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies. The company is focused on in-licensing and advancing promising programs from discovery through preclinical and clinical development stages.
Founders & leadership
PP
Pietro Puglisiin𝕏Chief Executive OfficerHe previously worked as an early-stage investor in biotech at Claris Ventures and holds an MSc in Biomedical Engineering from Politecnico di Torino and an MBA from Collège des Ingénieurs.
Investors · 5
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundDec 2025
Claris Ventures, Club degli Investitori, Italian Angels for Growth, Ora Global
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Lever Bio do?
- Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies. The company is focused on in-licensing and advancing promising programs from discovery through preclinical and clinical development stages.
- Who are Lever Bio's investors?
- Lever Bio's investors include Claris Ventures, Exor Ventures, Italian Angels for Growth, Club degli Investitori, Ora Global.